Gastrointestinal Stability and Microbiota-Mediated Deglycosylation of Triterpene Glycosides from Cimicifuga racemosa Extract Ze 450
- 1Medical Department, Max Zeller Söhne Aktiengesellschaft, 8590 Romanshorn, Switzerland
- 2Laboratory of Food Biotechnology, Eidgenössische Technische Hochschule Zürich, 8092 Zürich, Switzerland
Abstract
Triterpene glycosides (TTGs) are characteristic constituents of Cimicifuga racemosa extract Ze 450 and may contribute to its pharmacological effects in the treatment of menopausal symptoms. This exploratory study investigated their gastrointestinal stability, transformation during incubation with human fecal microbiota, and potential effects on microbial community composition and short-chain fatty acid (SCFA) production. The stability of 23-epi-26-deoxyactein was assessed during simulated oral and gastric digestion using the INFOGEST protocol. Microbiota-associated biotransformation of actein, 23-epi-26-deoxyactein, cimigenol-3-β-D-xyloside, and cimigenol-3-α-L-arabinoside was subsequently examined during 48 h anaerobic ex vivo cultivation with fecal microbiota from eight female donors. 23-Epi-26-deoxyactein remained largely stable during simulated oral and gastric digestion. During fecal incubation, all investigated TTGs were depleted and the corresponding aglycones were detected. Quantification of the 23-epi-26-deoxyactein aglycone revealed marked donor-dependent differences, indicating substantial interindividual variability in TTG biotransformation. Individual TTGs had little effect on microbial community composition or SCFA profiles, whereas Ze 450 induced a small but significant shift in overall community structure without substantially affecting SCFA production. These findings demonstrate extensive microbiota-mediated TTG deglycosylation and highlight marked interindividual variability in TTG metabolism, providing a rationale for further investigation of microbiome-dependent differences in the pharmacological fate of Ze 450.
Related
- Letter to the Editor: Structural Revision of Previously Reported Three Flavanone Glycosides Based on Empirical Rules for Substituent-Induced ¹³C-NMR Chemical Shifts
- Stereoselective Synthesis of β‐C‐glycosides From Exoglycals Through Radical C─C Bond Formation
- Photocatalytic Direct Desulfurization of Glycosyl Thiols via Glycosyl Radicals for the Synthesis of gem -Difluoroalkene C -Alkyl Glycosides
- Hexahydrofarnesyl as an original bio-sourced alkyl chain for the preparation of glycosides surfactants with enhanced physicochemical properties
- Direct Access to Alkyl Amide N ‐Glycosides via Transition‐Metal‐Free Visible‐Light Carbonylation of Glycosylamines
BibTeX
@article{senn2026gastrointestinal,
title = {{Gastrointestinal Stability and Microbiota-Mediated Deglycosylation of Triterpene Glycosides from Cimicifuga racemosa Extract Ze 450}},
author = {Roman Senn and Benoit Pugin and Verena M. Merk and Denisa Mujezinovic and Janina Zünd and Georg Boonen and Christophe Lacroix and Veronika Butterweck},
journal = {Molecules},
year = {2026},
month = nov,
doi = {10.3390/molecules31213928},
url = {https://www.mdpi.com/1420-3049/31/21/3928},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Gastrointestinal Stability and Microbiota-Mediated Deglycosylation of Triterpene Glycosides from Cimicifuga racemosa Extract Ze 450
AU - Roman Senn
AU - Benoit Pugin
AU - Verena M. Merk
AU - Denisa Mujezinovic
AU - Janina Zünd
AU - Georg Boonen
AU - Christophe Lacroix
AU - Veronika Butterweck
PY - 2026
DA - 2026/11/01
JO - Molecules
DO - 10.3390/molecules31213928
UR - https://www.mdpi.com/1420-3049/31/21/3928
AB - Triterpene glycosides (TTGs) are characteristic constituents of Cimicifuga racemosa extract Ze 450 and may contribute to its pharmacological effects in the treatment of menopausal symptoms. This exploratory study investigated their gastrointestinal stability, transformation during incubation with human fecal microbiota, and potential effects on microbial community composition and short-chain fatty acid (SCFA) production. The stability of 23-epi-26-deoxyactein was assessed during simulated oral and gastric digestion using the INFOGEST protocol. Microbiota-associated biotransformation of actein, 23-epi-26-deoxyactein, cimigenol-3-β-D-xyloside, and cimigenol-3-α-L-arabinoside was subsequently examined during 48 h anaerobic ex vivo cultivation with fecal microbiota from eight female donors. 23-Epi-26-deoxyactein remained largely stable during simulated oral and gastric digestion. During fecal incubation, all investigated TTGs were depleted and the corresponding aglycones were detected. Quantification of the 23-epi-26-deoxyactein aglycone revealed marked donor-dependent differences, indicating substantial interindividual variability in TTG biotransformation. Individual TTGs had little effect on microbial community composition or SCFA profiles, whereas Ze 450 induced a small but significant shift in overall community structure without substantially affecting SCFA production. These findings demonstrate extensive microbiota-mediated TTG deglycosylation and highlight marked interindividual variability in TTG metabolism, providing a rationale for further investigation of microbiome-dependent differences in the pharmacological fate of Ze 450.
SN - 1420-3049
ER -